A clinical trial to study the effects of two drugs, mesalamine and prednisolone in patients with ulcerative colitis
Not Applicable
- Conditions
- Health Condition 1: null- Ulcerative Colitis
- Registration Number
- CTRI/2014/11/005177
- Lead Sponsor
- Department of Gastroenterology PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Moderately active ulcerative colitis,
Patients not receiving any treatment, or left treatment for more than one month
Exclusion Criteria
patients not giving consent,
severe disease requiring intravenous drugs and/or hospitalization
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mucosal healing defined as absence of friability, blood, erosions and ulcers in all visualized segments of the gut mucosa.Timepoint: at 6 weeks
- Secondary Outcome Measures
Name Time Method Clinical remissionTimepoint: 6 weeks